Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Rezolute, Inc. (RZLT) Market Cap & Valuation Ratios

Rezolute, Inc. (RZLT) has a market cap of $372.9M, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

RZLTRezolute, Inc.Follow RZLT — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
372.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Peers

drug manufacturers - general · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
RZLT0.4——————-105%
CBIO0.5—25.6—————
DMAC0.5———-6.7%——-139%
OVID0.4—192.4—-13.0%-76%—-52%
ASMB0.4—1.1—-9.5%+125%-12%-3%
NBP0.4———-5.6%——-587%
GALT0.3———————
CTNM0.3——————-35%
TTRX0.3———-1.4%———
BNTC0.3———-5.5%———
PRLD0.3—6.2—-11.5%+220%-301%-86%
Median of these 10—15.9—-6.7%+125%-156%-69%

.

Growth vs. price

each dot a company · hover or tap for values

Rezolute, Inc. — questions

What is Rezolute, Inc.'s market cap?
$372.9M.

Every figure on this page comes from Rezolute, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.